Subscribe to stay informed!
A global nonprofit partnership has awarded Malvern-based VenatoRx Pharmaceuticals $4.1 million to develop a treatment for a drug-resistant STD, writes John George…
Before we send you to this site, please subscribe to our daily newsletter.